Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1350 of 2529 entries
View as:

Effect of QVA149 Versus NVA237 and Tiotropium on Chronic Obstructive Pulmonary Disorder (COPD) Exacerbations

Phase: N/A Priority: Normal
NCT ID: NCT01120691 Org: User:
Start: 04/30/10 End: 07/31/12 Due: 07/31/13

Assessment of Pruritus Improvement With Pimecrolimus Treatment on the Areas Affected by Mild-to-moderate AD, in Patients 2- to 11- Year-old

Phase: N/A Priority: Normal
NCT ID: NCT00510003 Org: User:
Start: 12/31/04 End: - Due: -

Safety, Pharmacokinetics and Preliminary Efficacy Study of CFZ533 in Patients With Primary Sjögren's Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT02291029 Org: User:
Start: 10/22/14 End: 06/29/18 Due: 06/29/19

Efficacy and Safety of Everolimus in Liver Transplant Recipients of Living Donor Liver Transplants

Phase: N/A Priority: Normal
NCT ID: NCT01888432 Org: User:
Start: 09/25/13 End: 04/21/18 Due: 04/21/19

Efficacy and Tolerability of BAF312 in Patients With Polymyositis

Phase: N/A Priority: Normal
NCT ID: NCT01801917 Org: User:
Start: 04/24/13 End: 08/05/16 Due: 08/05/17

A Phase I Study of LEE011 in Asian Patients

Phase: N/A Priority: Normal
NCT ID: NCT01898845 Org: User:
Start: 05/31/13 End: 01/31/15 Due: 01/31/16

PDR001 Plus LAG525 for Patients With Advanced Solid and Hematologic Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT03365791 Org: User:
Start: 01/24/18 End: 09/17/20 Due: 09/17/21

Efficacy and Safety of Indacaterol Plus Tiotropium Versus Tiotropium Alone in Patients With Chronic Obstructive Pulmonary Disease

Phase: N/A Priority: Normal
NCT ID: NCT00846586 Org: User:
Start: 03/31/09 End: 03/31/10 Due: 03/31/11

Study of Nilotinib as First Line Treatment in Philadelphia Chromosome Positive(Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)

Phase: N/A Priority: Normal
NCT ID: NCT01274351 Org: User:
Start: 01/25/11 End: 08/01/19 Due: 08/01/20

Phase III Study of BKM120/Placebo With Fulvestrant in Postmenopausal Patients With Hormone Receptor Positive HER2-negative Locally Advanced or Metastatic Breast Cancer Refractory to Aromatase Inhibitor

Phase: N/A Priority: Normal
NCT ID: NCT01610284 Org: User:
Start: 08/07/12 End: 04/19/19 Due: 04/19/20

Trial to Assess the Effect of Long Term Dosing of Inclisiran in Subjects With High CV Risk and Elevated LDL-C

Phase: N/A Priority: Normal
NCT ID: NCT03814187 Org: User:
Start: 04/16/19 End: 02/13/23 Due: 02/13/24

Inspiratory Flow Rates Achieved by the COPD Patients Through Breezhaler®, Ellipta® and Handihaler® Inhaler Devices

Phase: N/A Priority: Normal
NCT ID: NCT02596009 Org: User:
Start: 12/16/15 End: 04/29/16 Due: 04/29/17

Eltrombopag Combined With Cyclosporine as First Line Therapy in Patients With Severe Acquired Aplastic Anemia

Phase: N/A Priority: Normal
NCT ID: NCT02998645 Org: User:
Start: 05/11/17 End: 05/30/22 Due: 05/30/23

The Effect of Tegaserod on Patterns of Flow in the Small Bowel of Patients With Irritable Bowel Syndrome (IBS)

Phase: N/A Priority: Normal
NCT ID: NCT00171431 Org: User:
Start: 11/30/04 End: 05/31/06 Due: 05/31/07

Study to Evaluate the Efficacy and Safety of Glycopyrronium or Indacaterol Maleate and Glycopyrronium Bromide Fixed-dose Combination Regarding Symptoms and Health Status in Patients With Moderate COPD Switching From Treatment With Any Standard COPD Regimen

Phase: N/A Priority: Normal
NCT ID: NCT01985334 Org: User:
Start: 02/14/14 End: 04/29/16 Due: 04/29/17

Efficacy and Safety Study of Secukinumab in Chinese Participants With Non-radiographic Axial Spondyloarthritis

Phase: N/A Priority: Normal
NCT ID: NCT04732117 Org: User:
Start: 07/21/21 End: 02/14/25 Due: 02/14/26

Efficacy and Safety of Vildagliptin in Combination With Insulin in Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00099931 Org: User:
Start: 05/31/04 End: 06/30/05 Due: 06/30/06

Plaque Psoriasis Efficacy and Safety With Secukinumab

Phase: N/A Priority: Normal
NCT ID: NCT02409667 Org: User:
Start: 05/07/15 End: 05/08/17 Due: 05/08/18

Efficacy, Safety and Tolerability of ACZ885 in Pediatric Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease

Phase: N/A Priority: Normal
NCT ID: NCT01302860 Org: User:
Start: 11/30/10 End: 11/30/14 Due: 11/30/15

Regulatory Post-Marketing Surveillance of Xolair® for Chronic Rhinosinusitis With Nasal Polyps

Phase: N/A Priority: Normal
NCT ID: NCT05626257 Org: User:
Start: 01/12/23 End: 04/15/25 Due: 04/15/26

Efficacy of Secukinumab Compared to Adalimumab in Patients With Psoriatic Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT02745080 Org: User:
Start: 04/03/17 End: 12/30/19 Due: 12/30/20

A Clinical Study to Assess the Effect of Vildagliptin on Postprandial Lipid Parameters in Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00099957 Org: User:
Start: 09/30/03 End: 06/30/05 Due: 06/30/06

Long-term Follow up Local Registry Study of Kymriah in South Korea

Phase: N/A Priority: Normal
NCT ID: NCT06785818 Org: User:
Start: 04/10/25 End: 12/30/39 Due: 12/30/40

24 Week Efficacy and 3-year Safety and Efficacy of Secukinumab in Active Psoriatic Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT01989468 Org: User:
Start: 04/10/14 End: 03/28/18 Due: 03/28/19

Clinical Study to Assess the Mode of Action of QBW251 in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT04268823 Org: User:
Start: 09/10/20 End: 09/20/22 Due: 09/20/23